Targeting GRK2 in the Heart
Description: Narrative (relevance): Elucidating new roles for GRK2 in regulating transcription and cellular content after cardiovascular injury and heart failure including targets within mitochondria will lead to a broader understanding of how GRK2 may be a novel therapeutic target. This includes how its targeted inhibition contributes mechanistically to either its canonical or non-canonical actions within the heart can improve future therapies. Accordingly, this proposal focusing on both novel mechanisms of GRK2 in the injured heart and studying how its targeted inhibition is therapeutic is timely and of significance.
Funding type: research
Funder scheme: R01
Start date: 1998-09-30
End date: 2024-03-31
Investigator: WALTER J. KOCH (lead)
Institution: Duke University
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 122
Funder award ID: R01HL061690
OpenAlex ID: G2944223717
